Raymond L. Erikson
Affiliations: | Molecular and Cellular Biology | Harvard University, Cambridge, MA, United States |
Area:
Reversible protein phosphorylation and cell proliferationWebsite:
https://www.mcb.harvard.edu/mcb/faculty/profile/raymond-l-erikson/Google:
"Raymond L. Erikson"Bio:
http://de.wikipedia.org/wiki/Raymond_L._Erikson
http://www.fas.harvard.edu/~biophys/Raymond_L_Erikson.htm
Mean distance: 8.18 | S | N | B | C | P |
Cross-listing: Cell Biology Tree
Parents
Sign in to add mentorWacław Szybalski | grad student | 1963 | UW Madison | |
(Molecular radiobiology of human cell lines) | ||||
Richard Franklin | post-doc | 1965 | University of Colorado, Denver |
Children
Sign in to add traineeKyung S. Lee | grad student | Harvard | |
Craig M. Crews | grad student | 1993 | Harvard |
Chin-Yo Lin | grad student | 2001 | Harvard |
John Blenis | post-doc | Harvard (Neurotree) | |
Sabine Ottilie | post-doc | Harvard & Radcliffe | |
Jonathan Chernoff | post-doc | 1988-1991 | Harvard (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hye-Lin H, Kwon T, Seon Bak I, et al. (2016) IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E- cadherin in mice. Oncotarget |
Yim H, Shin SB, Woo SU, et al. (2016) Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity. Oncogene |
Thimmegowda NR, Park C, Shwetha B, et al. (2015) Synthesis and antitumor activity of natural compound aloe emodin derivatives. Chemical Biology & Drug Design. 85: 638-44 |
Goda AE, Erikson RL, Sakai T, et al. (2015) Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies. Molecular Oncology. 9: 309-22 |
Yim H, Woo S, Shin S, et al. (2015) Abstract 3773: Plk1-mediated stabilization of 53BP1 suppresses centrosome abnormal amplification Cancer Research. 75: 3773-3773 |
Park SY, Park JE, Kim TS, et al. (2014) Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis. Nature Structural & Molecular Biology. 21: 696-703 |
Yim H, Erikson RL. (2014) Plk1-targeted therapies in TP53- or RAS-mutated cancer. Mutation Research. Reviews in Mutation Research |
Liu H, Hwang J, Li W, et al. (2014) A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1. Cancer Prevention Research (Philadelphia, Pa.). 7: 74-85 |
Kim TS, Park JE, Shukla A, et al. (2013) Hierarchical recruitment of Plk4 and regulation of centriole biogenesis by two centrosomal scaffolds, Cep192 and Cep152. Proceedings of the National Academy of Sciences of the United States of America. 110: E4849-57 |
Liu H, Liu K, Huang Z, et al. (2013) A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases. The Journal of Biological Chemistry. 288: 25924-37 |